跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
L-44
首页
药物
L-44
L-44
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
GHRH or analogues thereof for use in treatment of hepatic disease
US 10799562 B1
申请人: MASSACHUSETTS GEN HOSPITAL
优先权: 2019
CN
US
6 件公开
Peptides with wound healing activity
US 2005176636 A1
申请人: ZAVERI CHANDA
优先权: 2001
US
5 件公开
NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
US 2008213187 A1
申请人: SCHMITT-WILLICH HERIBERT
优先权: 2007
CN
EP
US
WO
4 件公开
STABILIZED POLYPEPTIDES
EP 4541814 A1
申请人: CYTIVA BIOPROCESS R & D AB
优先权: 2023
CN
EP
WO
4 件公开
Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
CN 103224495 B
申请人: GUERBET SA
优先权: 2005
CN
EP
4 件公开
Nutrient rich germinant composition and spore incubation method
US 10610552 B2
申请人: NCH CORP
优先权: 2016
CN
US
3 件公开
MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM A GLUTAMINE SYNTHETASE GENE AND USES THEREOF
WO 2010026443 A1
申请人: CELLECTIS
优先权: 2008
CN
WO
2 件公开
IMMUNOGLOBULIN-BINDING PROTEIN
EP 4703372 A1
申请人: TOSOH CORP
优先权: 2023
CN
EP
2 件公开
METHOD OF USE OF PEPTIDE INHIBITORS IN CANCER TREATMENT
EP 4766722 A1
申请人: UNIV ISTANBUL TEKNIK
优先权: 2023
EP
WO
2 件公开
Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases
EP 1481686 A1
申请人: APOXIS SA
优先权: 2003
EP
2 件公开
第 1 / 5 页
上一页
下一页
药物
反馈